Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2006 Abstracts: Predicting Unresectability in Pancreatic Cancer Patients: The Additive Effects of CT Scanning and Endoscopic Ultrasound
Back to 2006 Program and Abstracts
Predicting Unresectability in Pancreatic Cancer Patients: The Additive Effects of CT Scanning and Endoscopic Ultrasound
Susannah Yovino1, Peter Darwin2, Barry Daly4, Michael Garofalo1, Robert Moesinger3; 1Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD; 2Division of Gastroenterology, Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, MD; 3Division of Surgical Oncology, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD; 4Department of Diagnostic Radiology, University of Maryland School of Medicine, Baltimore, MD

Background: Accurate preoperative staging optimizes treatment of pancreatic cancer. Predicting unresectability in many cases is very difficult, despite advances in diagnostic imaging technology. We propose a scoring system using computed tomography (CT) scan and endoscopic ultrasound (EUS) that more accurately predicts unresectability in patients with pancreatic cancer than either modality alone. Methods: Reports of preoperative EUS and CT scans from 79 patients who underwent exploration for pancreatic cancer were reviewed, as were operative notes and surgical pathology reports. Chi-squares were used to identify radiologic factors significantly correlated with unresectability. A total of five factors were identified as predictors of unresectability and incorporated into a scoring system. Each patient received a score of 0-5 by counting the number of criteria fulfilled. Results: Five criteria were identified that predicted unresectability: 1) suspicious liver lesions too small to biopsy or characterize (p < 0.001); 2) adenopathy (> 1 cm) identified by EUS (p = 0.05); 3) adenopathy (> 1 cm, long axis) identified by CT (p < 0.001; 4) suspicion of vascular involvement on EUS (p < 0.001); and 5) suspicion of vascular involvement on CT (p 0.53; specificity 91%). Patients with scores of 0, 1, 2, and 3 had resectability rates of 83.0%, 36.7 %, 15.4%, and 0%, respectively. The most accurate results were achieved in the group of 49 patients who were evaluated with CT and EUS. In this group of patients, all unresectable patients had a score ≥ 1. 24/30 resectable patients who underwent both CT and EUS had a score of “0,” for an overall accuracy of 88.2%. Conclusion: We propose a scoring system combining EUS and CT to assess risk for unresectability in pancreatic cancer. This scoring system is an effective method of stratifying pancreatic cancer patients into three groups: 1) patients with a score of zero: high probability (83.0%) of successful resection; 2) patients with a score of one: mediocre probability (36.7%) of successful resection; and 3) patients with a score of two or higher: low probability (11.1%) of successful resection. This stratification of resection probabilities can be used to guide surgical management.


Back to 2006 Program and Abstracts


Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards